Supplementary table 1 - Questions in the survey

In June 2023, patients with AD were interviewed about their treatment preferences for AD, includ-ing characteristics such as onset of action, side effects, and preferred administration route. Participants were asked various questions regarding treatment preferences and were instructed to select the statement they found most accurate.